Testicular toxicity arises when chemical, physical or biological agents disrupt the finely tuned processes of spermatogenesis, leading to impaired germ‐cell development, reduced sperm quality and ...

(a) Overgrowth of round cells with eosinophilic cytoplasm in a sheet-like growth pattern. Note the residual teratomatous (glandular) component in the right upper corner. (b) High-power view of the ...

Testicular germ cell tumours represent the most common malignancy in young men and are broadly classified into seminomas and non-seminomas. Primary management involves radical orchiectomy for ...

Seminoma, a type of testicular cancer that predominantly affects young men, is the most common testicular germ cell tumor and is characterized by its similarity to primordial germ cells (PGCs), the ...

Phase I trial of chidamide, an oral HDAC inhibitor, in combination with oral etoposide in patients with refractory/recurrent neuroblastoma. Type II RAF inhibitor tovorafenib in relapsed/refractory ...

Primary retroperitoneal germ-cell tumours (pR-GCT): Evaluation of treatment outcomes of an international retrospective collaboration (PRIMERE study). This is an ASCO Meeting Abstract from the 2024 ...

Testicular germ cell tumors are on the rise in the US. The incidence among Hispanic men now surpasses that of non-Hispanic White men, who have historically had the highest incidence. The incidence of ...

Scientists have identified new gene faults and evolutionary patterns contributing to testicular cancer. Their findings offer profound insights into the development of the disease and into potential ...

miR-371a-3p has clinical utility as a marker of residual disease and recurrence in clinical stage 1 testicular germ cell tumor, following orchidectomy. In patients with clinical stage 1 testicular ...

My cousin, who's in his late 20s, was recently diagnosed with testicular cancer. I didn't know this is something younger guys ...

A new study co-led by WEHI has found a simple blood test can help identify the early-stage testicular cancer patients who are most at-risk of cancer relapse. The CLIMATE study found a protein, which ...

Among patients with testicular cancer and paraneoplastic neurologic syndromes (PNS), most developed the neurological symptoms — including ataxia, hearing loss, and vertigo — before their cancer ...